Blog and News

FDA tries to encourage development of generic versions of complex drugs

FDA commissioner, Scott Gottlieb, has recently announced some new measures being taken to potentially slow the rise of prescription drug prices in the US. Although the FDA does not directly play a role in setting drug prices, Gottlieb believes the agency’s policies can improve competition in the market, which should indirectly affect the costs patients must pay to receive medications ...Read More
1 2 3 13